Home › Research › Vascular contributions
Associations of Accelerated Biological Aging With the Presence and Longitudinal Progression of Cerebral Small Vessel Disease
Mengxing Wang, Xueli Cai, Peiyuan Gao, Yingying Yang, Yueru Ding, Ziyan Zhang, Jingping Sun, Yanli Zhang et al.. Neurology, 2026-04-10
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
= 0.028), but not with progression of BG-EPVS or WMHs at follow-up. PhenoAge residual showed results consistent with those of KDMAge residual, whereas HDAge residual showed no significant association with progression of CSVD or its imaging markers. This community-based cohort study demonstrated that BA residuals, particularly KDMAge and PhenoAge, were associated with higher odds of CSVD progression, especially with development of new lacunes and new CMBs. Biomarker-based BA residual may help identify individuals at higher risk of clinically relevant CSVD progression. Future studies with longer follow-up periods and more diverse cohorts are warranted to validate these findings.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. This community-based cohort study found that accelerated biological aging was associated with higher odds of cerebral small vessel disease progression, especially new lacunes and new microbleeds. It suggests biological age markers may help identify people at higher risk, but does not test any treatment or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wang, M., Cai, X., Gao, P., Yang, Y., Ding, Y., Zhang, Z., et al. (2026). Associations of Accelerated Biological Aging With the Presence and Longitudinal Progression of Cerebral Small Vessel Disease. Neurology. https://doi.org/10.1212/wnl.0000000000214818
Vancouver
Wang M, Cai X, Gao P, Yang Y, Ding Y, Zhang Z, et al. Associations of Accelerated Biological Aging With the Presence and Longitudinal Progression of Cerebral Small Vessel Disease. Neurology. 2026. doi:10.1212/wnl.0000000000214818. PMID: 41962120.
BibTeX
@article{wang2026-41962120,
author = {Wang, Mengxing and Cai, Xueli and Gao, Peiyuan and Yang, Yingying and Ding, Yueru and Zhang, Ziyan and Sun, Jingping and Zhang, Yanli and others},
title = {{Associations of Accelerated Biological Aging With the Presence and Longitudinal Progression of Cerebral Small Vessel Disease}},
journal = {Neurology},
year = {2026},
doi = {10.1212/wnl.0000000000214818},
pmid = {41962120},
url = {https://doi.org/10.1212/wnl.0000000000214818}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- = 0.028), but not with progression of BG-EPVS or WMHs at follow-up.
- PhenoAge residual showed results consistent with those of KDMAge residual, whereas HDAge residual showed no significant association with progression of CSVD or its imaging markers.
- This community-based cohort study demonstrated that BA residuals, particularly KDMAge and PhenoAge, were associated with higher odds of CSVD progression, especially with development of new lacunes and new CMBs.
- Biomarker-based BA residual may help identify individuals at higher risk of clinically relevant CSVD progression.
- Future studies with longer follow-up periods and more diverse cohorts are warranted to validate these findings.
Why it matters
This community-based cohort study found that accelerated biological aging was associated with higher odds of cerebral small vessel disease progression, especially new lacunes and new microbleeds. It suggests biological age markers may help identify people at higher risk, but does not test any treatment or prevention.
Study details
- Study designcohort study
- Evidence strengthModerate
How this study scored 51/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 4 / 6 | Cited 8.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Yuesong Pan: h-index 61 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Capital Medical University: institution h-index 643 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41962120) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Vascular contributions from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.